Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Medipure Holdings

2014 FOUNDED
PRIVATE STATUS
PIPE LATEST DEAL TYPE
3 FINANCING ROUNDS
Description

Provider of research and development in the field of cannabinoid science. The company is a biopharmaceutical company focused on developing and marketing novel cannabinoid-based prescription medicines through its subsidiary, Medipure Pharmaceuticals.

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Primary Office
  • 999 Canada Place
  • Suite 404
  • Vancouver, British Columbia V6C 3E2
  • Canada

Medipure Holdings Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Medipure Holdings‘s full profile, request access.

Request full access to PitchBook

Medipure Holdings Executive Team (3)

Name Title Board
Seat
Contact
Info
Boris Weiss Chief Executive Officer
Mehrun Payravi Chief Operating Officer
John Maynard Chief Medical Officer & Medical Director